BioSpace News Archive

Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2019 results.

Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinical data on the mechanism of action of nesolicaftor (PTI-428).

Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the registration and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today announced that Dr. Nick Glover, President and Chief Executive Officer, will present an overview of the company entitled “Building MOMENTUM for Patients with Myelofibrosis” at the Cowen 40th Annual Health Care Conference

Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced that Steve Paul, M.D., chief executive officer, president and chairman of Karuna Therapeutics, will present at the Cowen and Company’s 40th Annual Health Care Conference being held at the Boston Marriott Copley Place in Boston, MA.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced it has reached the 100 patient enrollment target for the Marigold Study.

Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today reported financial results for its fourth quarter and full year 2019 ended December 31, 2019.

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the Cowen and Company’s 40th Annual Health Care Conference on Monday, March 2, 2020 at 2:50 p.m. Eastern in Boston, Massachusetts.

Auxly Cannabis Group Inc. (TSX.V - XLY) (“Auxly” or the “Company”) is pleased to announce that it has entered into a supply agreement with its strategic partner, Delta 9 Cannabis Inc. (“Delta 9”) in which the Company will supply cannabis products to Delta 9’s multiple retail locations, where permitted.

Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement with Artizan Biosciences, Inc. (“Artizan”) for the use of the Trianni Mouse®, a transgenic mouse R&D platform for the discovery of fully-human monoclonal antibodies, to support Artizan’s antibody-based therapeutic discovery programs.

Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that Company management will participate at the following upcoming investment conferences in March.